ILKAP and pancreatic adenocarcinoma: Then, variables with p-value ≤ 0.1 were included for multivariate regression analysis, and the conclusion that PHLPP2 and ILKAP favored PAAD patients’ survival was confirmed by multivariate Cox regression analysis (p < 0.05, Figure 3E,F).